Manulife (Manufacturers Life Insurance)
UBX

Manulife (Manufacturers Life Insurance)’s Unity Biotechnology UBX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,346
Closed -$141K – 3292
2021
Q1 		$141K Sell
2,346
-60
-2% -$4.09K ﹤0.01% 2993
2020
Q4 		$126K Buy
2,406
+322
+15% +$15.5K ﹤0.01% 2909
2020
Q3 		$72K Hold
2,084
– – ﹤0.01% 2862
2020
Q2 		$181K Buy
2,084
+119
+6% +$8.82K ﹤0.01% 2550
2020
Q1 		$114K Buy
1,965
+197
+11% +$12.4K ﹤0.01% 2541
2019
Q4 		$127K Sell
1,768
-62
-3% -$4.37K ﹤0.01% 2736
2019
Q3 		$114K Buy
1,830
+12
+0.7% +$849 ﹤0.01% 2796
2019
Q2 		$173K Buy
+1,818
New +$155K ﹤0.01% 2717

Other funds holding UBX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s UBX Position: Q2 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Unity Biotechnology (UBX) in Q2 2021, closing a stake of 2,346 shares — an estimated $141K sold.

Manulife (Manufacturers Life Insurance) first reported a position in UBX in Q2 2019 and held it in 8 quarters. The position peaked at $181K in Q2 2020. 98 funds tracked by Wall St. Rank hold UBX as of Q2 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Unity Biotechnology position as of Q2 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 2,346 Unity Biotechnology shares in Q2 2021, an estimated $141K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Unity Biotechnology in Q2 2019 and held it in 8 quarters.
  • Manulife (Manufacturers Life Insurance)'s Unity Biotechnology position peaked at $181K in Q2 2020.
  • 98 funds tracked by Wall St. Rank held Unity Biotechnology as of Q2 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2021, filed 12 Aug 2021.